No doubt investors would have waited for the CR to be addressed to buy back (now IMU are fully funded for 12 months) but the pps shouldn't have dropped to this low in the first place. A slow climb back to 10c end of this month before the next clinical trial update would set the pps up perfectly for the real rerate in 3-6 months (unlike the false one to 15c 12 months ago).
Add to My Watchlist
What is My Watchlist?